Ekso Bionics Accepted Into NVIDIA Connect Program to Accelerate Product Development
Ekso Bionics Holdings (Nasdaq: EKSO) has been accepted into the NVIDIA Connect program, which helps software development companies and service providers to accelerate product development, improve cost efficiency, and shorten time to market.
“The company plans to use the valuable tools and resources provided through this prestigious NVIDIA program to support a new strategic initiative to build a proprietary foundation model for human motion, and to help develop and integrate related new artificial intelligence capabilities across its portfolio of enterprise health and personal health devices,” Ekso Bionics said in a May 15 press release.
“We are privileged to join a select group of medical device innovators in the NVIDIA Connect program,” said Scott Davis, CEO of Ekso Bionics. “While our advanced exoskeleton technology platforms are already state of the art, in some ways we are only just approaching the starting line as we work to build and leverage what we believe will be the industry’s first known foundation model for human motion in physical rehabilitation. We are excited for this journey with NVIDIA Connect and look forward to updating all of our stakeholders as we progress.”
CRT Legislative Fly-In Scheduled for September
Summer is just getting started, but three Complex Rehab Technology (CRT) organizations are asking stakeholders to mark their calendars for Sept. 16-17, the dates of this year’s Washington, D.C., legislative fly-in.
The National Coalition for Assistive & Rehab Technology (NCART), the International Registry of Rehab Technology Suppliers (iNRRTS), and U.S. Rehab are hosting the event and said they will have more details soon.
